Admission to Treatment With DAAs in Patients With Chronic Hepatitis C: Are the Actual Criteria Based on Elastography Correct?

Gastroenterology, Hepatology and Endoscopy
doi 10.15761/ghe.1000116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Open Access Text Pvt, Ltd.

Related search

Editorial: Interferon-Free DAAs Are a Great Boon for Patients With Hepatitis C and Cryoglobulinaemia

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Treatment of Rheumatoid Arthritis in Patients With Concomitant Chronic Hepatitis C Infection

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2011English

Editorial: Combining Elastography With Blood Test for Fibrosis Assessment in Chronic Hepatitis C

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Pharmacist Intervention in Treatment of Patients With Genotype 1 Chronic Hepatitis C

Journal of Managed Care Pharmacy
2009English

Inflammatory Patterns in Patients With Chronic Hepatitis C

BMC Infectious Diseases
Infectious Diseases
2013English

Pseudouridine for Monitoring Interferon Treatment of Patients With Chronic Hepatitis C

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
1996English

Retreatment of Patients With Chronic Hepatitis C

Hepatology
MedicineHepatology
2002English

The Distribution of Hepatitis C Virus Genotypes in Patients With Chronic Hepatitis C Infection

Türk Mikrobiyoloji Cemiyeti Dergisi
2016English

PSY48 Developing a National Outcomes Treatment Registry for Hepatitis C Patients in the Era of the DAAs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy